Eksempler på brug af Tasigna på Engelsk og deres oversættelser til Dansk
{-}
-
Medicine
-
Colloquial
-
Official
-
Financial
-
Ecclesiastic
-
Official/political
-
Computer
What is Tasigna used for?
Other information about Tasigna.
Andre oplysninger om Tasigna.How has Tasigna been studied?
Hvordan blev Tasigna undersøgt?How to store Tasigna 6.
Sådan opbevarer du Tasigna 6.Why has Tasigna been approved?
Hvorfor blev Tasigna godkendt?What is the risk associated with Tasigna?
Hvilken risiko er der forbundet med Tasigna?Stop Tasigna, and monitor blood counts.
Stop Tasigna, og monitorér blodbillede.How to take Tasigna 4.
Sådan skal du tage Tasigna 4.Always take Tasigna exactly as your doctor has told you.
Tag altid Tasigna nøjagtigt efter lægens anvisning.These medicines should be avoided during your treatment with Tasigna.
Disse lægemidler bør undgås under behandling med Tasigna.What benefit has Tasigna shown during the studies?
Hvilken fordel viser undersøgelserne, at der er ved Tasigna?Tasigna was not compared to any other treatment.
Tasigna blev ikke sammenlignet med andre former for behandling.The Committee recommended that Tasigna be given marketing authorisation.
Udvalget anbefalede udstedelse af markedsføringstilladelse for Tasigna.Tasigna is used in the‘ chronic' and‘ accelerated' phases of CML.
Tasigna anvendes i de“ kroniske” og“ accelererede” faser af CML.If you think you may be allergic,tell your doctor before taking Tasigna.
Hvis du mener, at du kan være overfølsom,skal du fortælle det til din læge, før du tager Tasigna.How much Tasigna to take• The starting dose is 800 mg per day.
Så meget Tasigna skal du tage• Startdosis er 800 mg dagligt.If you have questions about when to take Tasigna, talk to your doctor or pharmacist.
Hvis du har spørgsmål om, hvornår du skal tage Tasigna, skal du tale med din læge eller apoteket.Tasigna is a medicine containing the active substance nilotinib.
Tasigna er et lægemiddel, der indeholder det aktive stof nilotinib.By blocking Bcr-Abl kinase, Tasigna helps to control the spread of leukaemia cells.
Ved at blokere Bcr- Abl- kinase hjælper Tasigna med at kontrollere spredningen af leukæmiceller.Tasigna can be given with certain other medicines if appropriate.
Tasigna kan anvendes sammen med visse andre lægemidler, når det er hensigtsmæssigt.Patients with hepatic impairment Tasigna has not been investigated in patients with hepatic impairment.
Patienter med leverinsufficiens Tasigna er ikke undersøgt hos patienter med leverinsufficiens.Tasigna blocks this signal, and thus stops the production of these cells.
Tasigna blokerer dette signal og stopper dermed produktionen af disse celler.Women should not breast-feed during treatment with Tasigna, as a risk to the infant cannot be excluded.
Kvinder bør ikke amme under behandling med Tasigna, eftersom risiko for barnet ikke kan udelukkes.Tasigna may be given with hydroxyurea or anagrelide if clinically indicated.
Tasigna kan gives med hydroxyurea eller anagrelid, hvis dette er klinisk indiceret.Pleural and pericardial effusions as well as complications of fluid retention occurred in<1% of patients receiving Tasigna.
Pleural og perikardiel effusion samt komplikationer med væskeretention forekom hos<1% af de patienter, der modtog Tasigna.Taking Tasigna with food and drink• Do not take Tasigna with food.
Brug af Tasigna sammen med mad og drikke• Du må ikke tage Most responders achieved their MCyR rapidly within 3 months(median 2.8 months) of starting Tasigna treatment and these were sustained median duration has not been reached.
De fleste respondenter opnåede deres MCyR hurtigt inden for 3 måneder(gennemsnitligt 2, 8 måneder) fra starten af Tasigna- behandlingen, og de blev.What Tasigna is Tasigna is a medicine containing an active substance called nilotinib.
Hvad Tasigna er Tasigna er et lægemiddel, der indeholder et aktivt stof kaldet nilotinib.You should also tell your doctor if you are already taking Tasigna andyou are prescribed a new medicine that you have not taken previously during Tasigna treatment.
Du skal fortælle det til lægen, hvis du allerede tager The Committee decided that Tasigna' s benefits are greater than its risks for the treatment of adults with chronic phase and accelerated phase Philadelphia chromosome positive CML with resistance or intolerance to prior therapy including imatinib.
Udvalget besluttede, at fordelene ved Tasigna er større end risiciene til behandling af voksne med Philadelphiakromosom positiv CML i kronisk eller accelereret fase, hvor forudgående behandling(herunder imatinib) ikke virker eller ikke tåles.
